Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Bertoletti

Showing results (61-70 of 224) with videos related to

Pageof 23
Sort By:
Diseases (Basel, Switzerland)|September 22, 2017
Targeted Therapy of Hepatitis B Virus-Related Hepatocellular Carcinoma: Present and FutureSarene Koh, Anthony Tanoto Tan, Lietao Li, et al.
Virologica Sinica|November 10, 2022
Protection from infection or disease? Re-evaluating the broad immunogenicity of inactivated SARS-CoV-2 vaccinesAnthony T Tan, Joey Ming Er Lim, Antonio Bertoletti
STAR Protocols|January 5, 2023
Protocol to detect antigen-specific nasal-resident T cells in humansJoey Ming Er Lim, Anthony T Tan, Antonio Bertoletti
Journal of Hepatology|February 19, 2020
Early treatment of chronic hepatitis B in children: Everything to play for?Antonio Bertoletti, Upkar S Gill, Patrick T F Kennedy
Nature Reviews. Drug Discovery|January 9, 2020
Author Correction: Therapeutic strategies for hepatitis B virus infection: towards a cureGregory C Fanning, Fabien Zoulim, Jinlin Hou, et al.
Gut|November 28, 2025
Decoding HBV-specific adaptive immunity: from natural clearance to cureRobert Thimme, Maike Hofmann, Antonio Bertoletti, et al.
Nature Reviews. Drug Discovery|August 29, 2019
Therapeutic strategies for hepatitis B virus infection: towards a cureGregory C Fanning, Fabien Zoulim, Jinlin Hou, et al.
Gastroenterology|March 9, 2017
ReplyPatrick T F Kennedy, Antonio Bertoletti, William S Mason
Cellular & Molecular Immunology|September 2, 2021
SARS-CoV-2-specific T cells in infection and vaccinationAntonio Bertoletti, Nina Le Bert, Martin Qui, et al.
Antiviral Research|May 29, 2026
Therapeutic vaccination for chronic hepatitis B: why most vaccines failed and what may workAntonio Bertoletti, Shubhankar S Ambike, Nina Le Bert, et al.
Pageof 23

Showing results (61-70 of 224) with videos related to

Sort By:
Pageof 23
Diseases (Basel, Switzerland)|September 22, 2017
Targeted Therapy of Hepatitis B Virus-Related Hepatocellular Carcinoma: Present and FutureSarene Koh, Anthony Tanoto Tan, Lietao Li, et al.
Virologica Sinica|November 10, 2022
Protection from infection or disease? Re-evaluating the broad immunogenicity of inactivated SARS-CoV-2 vaccinesAnthony T Tan, Joey Ming Er Lim, Antonio Bertoletti
STAR Protocols|January 5, 2023
Protocol to detect antigen-specific nasal-resident T cells in humansJoey Ming Er Lim, Anthony T Tan, Antonio Bertoletti
Journal of Hepatology|February 19, 2020
Early treatment of chronic hepatitis B in children: Everything to play for?Antonio Bertoletti, Upkar S Gill, Patrick T F Kennedy
Nature Reviews. Drug Discovery|January 9, 2020
Author Correction: Therapeutic strategies for hepatitis B virus infection: towards a cureGregory C Fanning, Fabien Zoulim, Jinlin Hou, et al.
Gut|November 28, 2025
Decoding HBV-specific adaptive immunity: from natural clearance to cureRobert Thimme, Maike Hofmann, Antonio Bertoletti, et al.
Nature Reviews. Drug Discovery|August 29, 2019
Therapeutic strategies for hepatitis B virus infection: towards a cureGregory C Fanning, Fabien Zoulim, Jinlin Hou, et al.
Gastroenterology|March 9, 2017
ReplyPatrick T F Kennedy, Antonio Bertoletti, William S Mason
Cellular & Molecular Immunology|September 2, 2021
SARS-CoV-2-specific T cells in infection and vaccinationAntonio Bertoletti, Nina Le Bert, Martin Qui, et al.
Antiviral Research|May 29, 2026
Therapeutic vaccination for chronic hepatitis B: why most vaccines failed and what may workAntonio Bertoletti, Shubhankar S Ambike, Nina Le Bert, et al.
Pageof 23